6 Takeaways from the Asembia 2022 Specialty Pharmacy Summit
6,000 pharmacy professionals attended Asembia this year. What were the key takeaways from the conference?
What Self-Funded Plans Should Know About Copay Assistance Programs
Plan sponsors are looking for new ways to contain specialty costs. How should they evaluate new copay assistance strategies?
How to Manage High-Cost Specialty Drug Spend for Self-Funded Plans
As pharmacy costs increase, what are strategies plan sponsors can take to control specialty pharmacy spend?
POV - Misaligned Incentives in the Pharmacy Ecosystem
Read Sally Welborn’s POV piece on the misaligned incentives at play in the pharmacy benefits ecosystem – and what it means for plan sponsors.
Webinar - Copay Maximizers and Alternative Funding: What Self-Funded Plans Should Know
How are copay maximizers and alternative funding impacting plans – and members? Watch our on-demand webinar to learn more.
Asembia 2021: Four Key Takeaways
Four core themes from Asembia 2021 that will drive dialogue in the specialty pharmacy ecosystem in 2022 – and beyond.
Webinar - Payer Strategies for Anticipating and Managing Gene Therapy
Watch Truveris’ on-demand webinar outlining how Payers can best anticipate and manage new gene therapies.
What’s the Difference between a Specialty Drug and a Non-Specialty Drug?
Looking forward to the future of pharmacy, it’s critical to understand how a specialty drug is defined, how it differs from traditional, non-specialty drugs, and how specialty is impacting employers’ benefit plan designs.